Early intervention and treatment options could soon become a reality in the treatment of ADHD, autism and schizophrenia, thanks to a breakthrough research study conducted by Australian scientists.

Scientists from the University of Queensland’s (UQ) Queensland Brain Institute (QBI) have discovered how molecular networks of the disorders function, allowing for the creation of a ‘gene network model’ that could be used to analyse the many candidate genes and predict the association of genetic screening data with autism, ADHD and schizophrenia. 

“For example, early diagnosis and clinical intervention will hopefully lead to better cognitive and psychosocial outcomes for an individual with autism, and associated benefits for family members and public health spending,” Associate Professor Claudianos said.

He said many studies had identified candidate gene associations for these mental health disorders, but previous studies had been conducted in a piecemeal fashion with little regard to the molecular complexity or genetic links between disorders. 

“We undertook a global and systematic approach to build and integrate all the available genetic data linked to autism, X-linked intellectual disability, ADHD and schizophrenia," he said. 

“The discovery of a large gene network comprised of 4000 genes represents a significant advance in understanding the basis of mental health disorders. 

"This gene network was successfully validated using cohort data from six recent disorder studies. 

“Although our analysis show that the many genetic variations with the four disorders can affect the same molecular pathways and biological functions, including how nerve cells connect (synapses), there are patterns of variation that define significant differences between disorders.”